Conférences  >  Médecine & Soins de Santé  >  Cancérologie  >  États-Unis

Thomas Jefferson University

The ultimate goal of this conference is improve the care of patients with pancreatic and related cancers by focusing on improvements to the diagnostic methods, treatment strategies, and supportive care. Through didactic lectures, case based presentations, and lively discussion with expert faculty, participants will review of the latest technologies and procedures and will be able to improve their delivery of care, determine the need for referrals sooner, and achieve better patient outcomes.

Office of CPD;     Tél.: [215-955-6992];     Email.: jeffersoncpd@jefferson.edu

Pancreas Cancer, Surgery, Gastroenterology

Binaytara Foundation

BTF Support;     Tél.: [4255575953];     Email.: support@binayfoundation.org

BTF, CME, cancer, oncology, binaytara, biomarkers, hematology, patientcare

Formation médicale continue (FMC),    Hématologie

Binaytara Foundation

This CME-accredited oncology conference, Best of ASCO 2023, Portland, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.

This oncology conference features some of the most well-known experts in the field of hematology and oncology who will provide a comprehensive overview of noteworthy data presented at the 2023 ASCO® Annual Meeting (ASCO2023) in June of 2023. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field and a scientific abstract session. Expert faculty will place abstract findings from ASCO2023 into clinical context and discuss how the results may change the current standard of care.

Event Planner;     Tél.: [4255575953];     Email.: shahtara@binayfoundation.org

ASCO, BTF

Binaytara Foundation

This CME-accredited oncology conference, BTF's 2023 Updates on Hematology and Oncology, is designed to improve the care of cancer patients by educating clinicians involved in cancer care. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field.

Tél.: [425-557-5953];     Email.: lerato_intern@binayfoundation.org

Oncology, cancer care, hematology.

Binaytara Foundation

This CME-accredited oncology conference, 2023 San Diego Hematology Oncology Conference, is designed to improve the care of cancer patients by educating clinicians involved in cancer care. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will place abstract findings from ASCO2023 into clinical contexts and discuss how the results may change the current standard of care.

Email.: lerato_intern@binayfoundation.org

Oncology, Hematology, cancer care

Binaytara Foundation

CME-accredited oncology conference being held in person in Seattle, WA. This conference features lectures and discussions with leading experts in cellular therapies. The goal of this oncology conference is to improve the knowledge, competence, and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients receiving cellular therapies for hematologic and non-hematologic disorders. The conference agenda includes an in-depth discussion and analysis of the latest scientific findings and practice-changing advances in chimeric antigen receptor (CAR) based therapies. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Event Planner;     Tél.: [4255575953];     Email.: support@binayfoundation.org

CLL/NHL, ALL, MULTIPLE MYELOMA, SOLID TUMORS, SUPPORTIVE CARE

Formation médicale continue (FMC),    Hématologie

Binaytara Foundation

This CME-accredited activity 2023 Annual Summit on Hematologic Cancers features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, multiple myeloma, and lymphoma.

Event Planner;     Tél.: [4255575953];     Email.: support@binayfoundation.org

Oncology, cancer, CME, hematology malengenices, acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, multiple myeloma, lymphoma, btf

Binaytara Foundation

The 2023 Midwest Precision Oncology Symposium, is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. Designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.

Event Planner;     Tél.: [4255575953];     Email.: support@binayfoundation.org

precision-oncology, oncology, molecular-targeted-treatment, molecular-targeted-therapies, CME, ACCME

Bio Ascend LLC

The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts—from laboratory-based research to the clinic—in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for 4 days every other year.

Chronic lymphocytic Leukemia, ( CLL)

Formation médicale continue (FMC),    Hématologie

Binaytara Foundation

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.

Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2023 ASCO Annual Meeting in June 2023.

Event Planner;     Tél.: [4255575953];     Email.: support@binayfoundation.org

oncology, CME-credits